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Background: Timely follow-up of fecal occult blood screening with colonoscopy is essential for achieving colorectal
cancer mortality reduction. This study evaluates the effectiveness of two ongoing interventions designed to
improve colonoscopy uptake after a positive fecal occult blood test (FOBT) result within Ontario’s population-wide
ColonCancerCheck program. The first was a revision of mailed FOBT lab results to physicians to explicitly define a
positive FOBT and to recommend colonoscopy. The second was a letter to participants informing them of
the positive FOBT and urging them to seek appropriate follow-up.
Methods: Prospective cohort study using Ontario’s ColonCancerCheck program data sets (2008–2011), linked
to provincial administrative health databases. Crude rate ratios were calculated to assess determinants of
colonoscopy uptake among an Ontario-wide FOBT-positive cohort with rolling enrolment, followed from October
2008 through February 2011. Segmented time-series regression was used to assess the average additional change in
colonoscopy uptake after FOBT-positive status following the introduction of two ongoing interventions among the
same cohort.
Results: A notification mailed directly to FOBT-positive screening participants was observed to increase colonoscopy
uptake, beyond the modest average underlying increase throughout the study period, by an average of 3% per month
(multivariable-adjusted RR: 1.03, 95% CI: 1.00–1.06). However, revision of the existing FOBT result notification to
physicians was observed to have no effect.
Conclusions: Direct participant notification of a positive FOBT result improved adherence with follow-up
colonoscopy in Ontario’s population-wide ColonCancerCheck program. Further participant-directed interventions
may be effective means of maximizing adherence in population-wide screening.
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In their lifetime, 1 in 13 men and 1 in 15 women are ex-
pected to develop colorectal cancer, the second and third
most common cause of cancer mortality for Canadians,
respectively [1]. Meta-analysis of four large randomized
controlled trials (RCT) from Sweden, Denmark, Eng-
land, and the United States has demonstrated biennial
fecal blood screening capable of reducing colorectal can-
cer mortality by approximately 15% [2,3]. When adjusted
for mean screening attendance, this risk was reduced by
25% (relative risk: 0.75; 95% CI: 0.66–0.84) [3]. However,
diagnostic colonoscopy after a positive fecal occult blood
test (FOBT) is essential for FOBT-derived colorectal can-
cer mortality reduction.
Canadian provinces have begun to implement population-
wide fecal occult blood screening programs, the first being
Ontario’s ongoing ColonCancerCheck (CCC), implemented
in April 2008 [4] by Cancer Care Ontario (CCO). The CCC
Program provides biennial screening with guaiac FOBT
kits (Hemoccult-II), distributed primarily by primary care
physicians (PCP), for average-risk individuals between
the ages of 50 and 74 years, inclusive, and recommends
follow-up of a positive result with colonoscopy. In
Ontario, colonoscopies are provisioned at the discre-
tion of the PCP or specialist, who has been instructed to
do so following a positive FOBT result. Over 3.9 million
Ontario residents are estimated to be within this age range
[5], comprising a substantial average-risk target screening
population. As of 2011, 74.6% of Ontarians receiving a
positive FOBT result proceeded to follow up colonoscopy
within 6 months [4]. While up from 63.4% in 2008, this
fell short of early results from European population-wide
screening programs implemented around the same time
[6,7] and targets based on Canadian consensus [8] guide-
lines. Factors most strongly associated with failure to fol-
low up with colonoscopy in Ontario are having had recent
colonoscopy and ordering of repeat FOBT [9].
To increase colonoscopy uptake following a positive
FOBT, CCC introduced two ongoing strategies as of
February and October of 2010. The first was a revision
of the existing FOBT result notification to PCPs to in-
clude an explicit definition of a positive FOBT result and
recommend timely follow-up with colonoscopy. The sec-
ond was a mailed letter to participants, informing them
of their positive FOBT result, and recommending them
to seek appropriate follow-up with their PCP. This study




Our population-wide perspective cohort comprised all
screening-aged Ontarians (50 to 74 years) who received
a positive FOBT result from September 1, 2008, throughFebruary 28, 2011, in the CCC program. In Ontario’s
CCC, FOBT participants collect two samples each from
three consecutive spontaneously passed stools onto indi-
vidual FOBT card windows. One or more positive sam-
ples, out of six windows, define a positive FOBT result.
FOBT-positive participants were eligible if they were
alive at the index date, defined henceforth as the date of
their first positive FOBT result within the study period,
following sample return. Exclusion criteria consisted of a
previous diagnosis of colorectal cancer (ICD-9: 153.0 to
153.4 and 153.6 to 154.1, inclusive); a positive result from
an FOBT ordered by a registered nurse, pharmacist, or via
Telehealth Ontario (rather than by a PCP); or missing in-
formation on age, sex, or postal code. Ethics approval was
granted by the Sunnybrook Research Ethics Board.
Data sources
The FOBT-positive cohort was identified using the CCC
Laboratory Reporting Tool (LRT) administrative data-
base. The LRT tracks the distribution of CCC-provided
FOBT kits and records results. The Ontario Health In-
surance Plan (OHIP), Ontario Cancer Registry (OCR),
Colorectal Interim Reporting Tool (CIRT), Canadian In-
stitute for Health Information (CIHI), and the Registered
Persons Database (RPDB) provided data required for
baseline exclusions, the ascertainment of outcome sta-
tus, and the derivation of covariates. The CIRT captures
the occurrence, findings, and quality-related measures of
colonoscopies performed in participating hospitals. Colon-
oscopies performed outside of participating hospitals are
captured by OHIP. The RPDB contains demographic in-
formation such as age, sex, and postal code from all those
registered for OHIP coverage. Detailed descriptions of
OHIP, OCR, CIHI, and RPDB have been published else-
where [10,11]. Access to, and linking of, the above data-
bases was facilitated by the Institute for Evaluative Clinical
Sciences (ICES), authorized by comprehensive data-sharing
agreements with Ontario’s Ministry of Health and Long
Term Care and CCO. ICES maintains anonymized admin-
istrative data on health care utilization on all OHIP-insured
Ontarians.
Strategies to improve colonoscopy uptake
In Ontario, the PCP who orders the FOBT is responsible
for organizing follow-up after a positive test. To improve
the uptake of colonoscopy after a positive FOBT result,
CCC implemented two ongoing interventions, beginning
February and October of 2010. The first (strategy 1) was
a revision of the mailed, standardized notification to the
ordering PCP to explicitly define a positive FOBT result
as one indicating at least one of six positive test kit win-
dows. PCPs were reminded of the corresponding recom-
mended course of action as follows: “Timely follow up
with colonoscopy is strongly recommended to rule out
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(Additional file 1) mailed directly to participants inform-
ing them of a positive FOBT result and urging them to
contact a PCP or nurse practitioner to discuss appropri-
ate diagnostic follow-up. Prior to the introduction of this
intervention, participants did not receive notification dir-
ectly from the CCC program of their positive FOBT re-
sult. Strategies 1 and 2 were implemented as of February
and October, 2010, respectively. Both were coexistent fol-
lowing the onset of strategy 2.
Study variables
Outcome
As there is no way to reliably identify screening colonos-
copy within OHIP records over the duration of the study
period, the outcome was colonoscopy irrespective of in-
dication. Colonoscopy dates were identified using CIRT
and OHIP databases. For the latter, events were identified
by the billing code Z555 with any of the following sub-
codes: E740, E741, E747, or E705, indicating colonos-
copies complete to splenic flexure, hepatic flexure, cecum,
and terminal ileum, respectively. The earliest colonoscopy
service date following a positive FOBT result in either
CIRT or OHIP databases was used to indicate timing of
the outcome. In Ontario, OHIP is a single payor for the
majority of health services, including colonoscopy, resulting
in strong incentivization for submission of OHIP billing
claims. As such, we expect the vast majority of colonoscopy
outcomes to have been captured.
Covariates
Covariates included age, sex, socioeconomic status (SES),
health region, aggregate comorbidity, continuity of pri-
mary care, repeat FOBT within 6 months post index posi-
tive FOBT, and occurrence of recent colonoscopy within
5 years prior to the index date. Health region was defined
by Local Health Integration Network (LHIN), ranked by
2007 fiscal year colonoscopy rates, in descending order of
colonoscopies per capita. SES status was an aggregate
measure, derived from average household income by
census dissemination area, divided into quintiles. Due
to the substantial variability of income in rural dis-
semination areas, those living in such regions were
assigned a sixth category. A comorbidity index was de-
rived using Aggregated Diagnosis Groups™ (ADG®) of the
Johns Hopkins Adjusted Clinical Group (ACG®) case-mix
system, previously validated for use with Ontario adminis-
trative health data [12]. Continuity of care was captured
using the Usual Provider Continuity (UPC) density meas-
ure, a commonly used index for this construct [13]. UPC
is the ratio of the number of visits to a usual primary care
provider to all other primary care providers. A ratio of
0.74 or lower was considered indicative of low continuity
of care [14]. For this study, the usual care provider wasconstrained as the PCP who ordered the index positive
FOBT.
Statistical analysis
Segmented linear [15] Poisson regression was used to as-
sess the effect of the two ongoing interventions (strategies
1 and 2) on colonoscopy uptake among FOBT-positive
CCC participants. The outcome was colonoscopy rate
per month. The numerator for this rate was the num-
ber of colonoscopies per month and the denominator
was person-time contributed by FOBT-positive individuals
each month. This model provided estimation of the baseline
rate, the linear trend in rate (i.e., slope) prior to strategy 1,
the difference in linear trend in rate pre- and post-strategy
1, and the difference in linear trend in rate pre- and post-
strategy 1 and 2 combined. Crude and multivariable-
adjusted rate ratios (RR) representing the estimated relative
monthly average change in colonoscopy rate, and add-
itional change post-strategy 1 and post-strategy 1 and 2,
are presented with 95% confidence intervals. Analyses were
conducted using SAS 9.3 (SAS Institute, Cary, North
Carolina).
Person-time contribution was truncated at date of
death and follow-up was constrained to a maximum of
3 months: an individual that had a positive FOBT in
1 month remained eligible for the outcome during the
following 2 months. This restriction facilitated the assess-
ment of strategy 2, for which only 5 months of follow-up
were available (October 2010 to February 2011, inclusive)
due to the introduction of a competing intervention. Add-
itionally, it focused results on colonoscopy uptake within
a timeframe approximately consistent with the 2-month
wait time recommended by the Canadian Association of
Gastroenterology [8], a target adopted by the CCC pro-
gram [16]. To verify whether modeled follow-up length
may have substantially altered estimated intervention ef-
fects, we performed a sensitivity analysis excluding the
strategy 2 study interval, allowing FOBT-positive partici-
pants to remain at risk for colonoscopy for up to
6 months.
Results
There were 81,283 person-months contributed by 39,105
Ontarians between 50 and 74 years of age with a positive
FOBT result between October 2008 and February 2011,
inclusive. The proportion of person-time contribution
prior to strategy 1, between strategy 1 and 2, and post-
strategy 2 was 50.2, 27.7, and 22.1 persons-months, re-
spectively, while 46.3%, 28.0%, and 25.7% of colonoscopy
service dates fell within these respective intervals. There
were 13,229 colonoscopies following a positive FOBT re-
sult during the 29-month study period.
Person-time contribution and observed colonoscopy rates
by positive FOBT participant characteristics, aggregated
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colonoscopy rate was 6% higher for those aged 50 to 69
(crude RR: 1.06; 95% CI:1.01–1.11), compared to those 70–
74 years, at index-positive FOBT. It was 10% higher in the
highest, relative to all other, urban SES quintiles (crude RR:
1.10, 95% CI: 1.05–1.15), while rural participants exhibited
a 16% lower rate compared to those in urban areas (crude
RR 0.84; 95% CI: 0.79–0.89). It was substantially lower for
participants who completed a repeat FOBT within 180 days
following the index-positive FOBT (crude RR: 0.24; 95% CI:
0.21–0.27) or for those that had a colonoscopy within the
past 5 years (crude RR: 0.67; 95% CI: 0.63–0.70).
Model-estimated colonoscopy rates increased by 7.8%,
8.7%, and 16.1% prior to implementation of strategy 1,
between implementation of strategy 1 and 2, and post-
implementation of strategy 2, respectively (Figure 1). Rate
ratios estimating the crude and multivariable-adjusted
average monthly change in colonoscopy uptake are pre-
sented in Table 2. Prior to strategy 1, there was a border-
line statistically significant 1% per month increase in
colonoscopy utilization (multivariable-adjusted RR: 1.01;
95% CI: 1.00–1.01). After the implementation of strategy
1, and prior to strategy 2, there was no additional increase
in estimated colonoscopy uptake. For post-strategy 2,
there was a borderline statistically significant 3% (multi-
variable-adjusted RR: 1.03; 95% CI: 1.00–1.06) additional
average increase, per month, in colonoscopy uptake.
Under the modeled constraint that the average back-
ground increase in colonoscopy utilization was constant
over the entire 29 months of follow-up, strategy 2 led to
an approximate 16% relative increase in colonoscopy up-
take between October 2010 and February 2011, inclusive.
Due to concerns that a maximum follow-up time of
3 months may not provide enough time for the interven-
tions to exert an effect on colonoscopy uptake, a model
allowing a 6-month maximum cohort membership was
explored for strategy 1. Results were not materially differ-
ent to those summarized in Table 1 (data not shown).
Discussion
To our knowledge, this is the first population-wide study
to directly evaluate interventions implemented to improve
colonoscopy uptake among Ontario’s CCC program partic-
ipants following a positive FOBT result. Strategy 2, mailed
notifications to participants including recommended
course of action, was observed to increase colonoscopy
uptake, beyond the modest average underlying increase
throughout the study period. Strategy 1, mailed notifica-
tions to PCPs to specify that colonoscopy is recommended,
was observed to have no effect. Crude-rate ratios corrobor-
ate other findings from Ontario [9] indicating that the
strongest determinants of not proceeding to colonoscopy
are repeat FOBT and recent colonoscopy, followed by fac-
tors related to socioeconomic status.The literature evaluating interventions specifically de-
signed to improve colonoscopy uptake after a positive
FOBT result is sparse. The existing evidence demonstrates
efficacy of those that target physicians and efficiency of
health care infrastructure. A 48% increased odds of complete
diagnostic evaluation (OR: 1.48; 95% CI: 1.04–2.11) was
observed in a US study assessing the combined impact of
physician reminders and practice-tailored educational out-
reach [17]. The study included 2,992 FOBT-positive pa-
tients over the age of 50 from 318 participating primary
care practices. A major discrepancy between this physician
reminder and notifications utilized in Ontario’s CCC pro-
gram was the emphasis on feedback in the former: partici-
pating physicians in the US study were asked to indicate
whether diagnostic follow-up had been recommended and
performed and provide examination dates and diagnoses
reached. PCP correspondence in the Ontario CCC pro-
gram does not solicit feedback, perhaps increasing the
likelihood of them going unheeded. However, the tracking
of PCP decision making in population-wide programs as
large as Ontario’s CCC would require extensive upgrades
to centralized health information infrastructure beyond
what is currently implemented in most settings, Ontario
included.
The majority of published intervention studies have
compared positive FOBT follow-up adherence pre- and
post-electronic medical record system and infrastructure
augmentations. Three studies conducted in US Veteran
Affairs (VA) centers found compelling evidence that
automatic gastroenterology referrals [18] and electronic
chart reminders with prompting of physician feedback
verifying appropriate action had been taken [19], or
manual-tracking resulting in further reminders in cases
of undocumented recommended follow-up [20], improve
adherence. A fourth VA-center-based prospective cohort
study with historical controls found that automatic gastro-
enterology referrals reduced time to (p < 0.0001), though
not proportion of (p = 0.77) patients completing colonos-
copy [21]. A fifth study within a large Seattle-based
integrated healthcare organization reported substantial
increases in recommended follow-up after the adoption of
electronic record tracking and, subsequently, a manual
audit system, propelling complete diagnostic evaluation
rates markedly higher than the national average [22]. In
contrast, FOBT results and subsequent reminders in
Ontario’s CCC are not maintained in a centralized elec-
tronic medical record database accessible to the PCP, are
not accompanied by automatic colonoscopy referrals, and
do not prompt PCP feedback verifying further action has
been taken. It should be emphasized that the scope of
Ontario’s CCC greatly exceeds that of the settings in
which the above interventions were evaluated. If improved
communication with PCPs can contribute to achieving
colonoscopy uptake targets, those that require extensive
Table 1 Person-time contribution and observed
colonoscopy rates across index-positive FOBT participant
characteristics from Ontario’s ColonCancerCheck
program, October 2008 through February 2011
Characteristics Person-months (%) Ratea
Total = 81,283
Age at index FOBT+ (years)
50 to 59 36,381 (44.8) 16.4
60 to 69 32,235 (39.7) 16.4
70 to 74 12,667 (15.6) 15.5
Sex
Females 36,600 (45.0) 16.2
Males 44,684 (55.0) 16.3
Urban SES quintiles/rural status
(lowest) Urban quintile 1 13,308 (16.4) 15.4
Urban quintile 2 15,320 (18.8) 16.4
Urban quintile 3 14,898 (18.3) 17.2
Urban quintile 4 14,805 (18.2) 16.7
(highest) Urban quintile 5 13,315 (16.4) 17.1
Rural 9,631 (11.8) 13.9
LHINb
(Highest) LHIN 1 3,644 (4.5) 11.7
LHIN 2 6,444 (7.9) 13.5
LHIN 3 4,749 (5.8) 16.6
LHIN 4 9,034 (11.1) 12.5
LHIN 5 9,150 (11.3) 16.9
LHIN 6 1,297 (1.6) 12.4
LHIN 7 4,010 (4.9) 13.3
LHIN 8 4,086 (5.0) 17.4
LHIN 9 3,481 (4.3) 11.1
LHIN 10 5,861 (7.2) 16.4
LHIN 11 6,211 (7.6) 17.1
LHIN 12 2,022 (2.5) 20.0
LHIN 13 10,385 (12.8) 18.1
(Lowest) LHIN 14 10,919 (13.4) 21.6
ADG scorec
0 or 1 9,169 (11.3) 16.3
2 or 3 25,476 (31.3) 16.5
4 or 5 21,637 (26.6) 16.8
6 or 7 13,438 (16.5) 16.4
≥8 11,559 (14.2) 14.7
Usual provider continuity indexd
Low 30,399 (37.4) 16.0
High 50,885 (62.6) 16.5
Repeat FOBTe
Yes 7,421 (9.1) 4.2
No 73,860 (90.9) 17.5
Table 1 Person-time contribution and observed
colonoscopy rates across index-positive FOBT participant
characteristics from Ontario’s ColonCancerCheck
program, October 2008 through February 2011
(Continued)
Prior colonoscopy
None 67,328 (82.8) 17.2
0 to 2 years 5,283 (6.5) 8.1
2 to 5 years 8,921 (11.0) 13.4
aObserved rate per 100 person-months.
bHealth region ranked by colonoscopy rates for the 2007 fiscal year.
cDerived Advanced Diagnosis Group index.
dHigh indicates that 75% or more of primary care services in the 2 years prior
to the index-positive FOBT were performed by the same physician.
eWithin 6 months post index FOBT.
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population-based programs such as Ontario’s CCC.
The literature specifically assessing strategies that dir-
ectly target participants is limited. A smaller Korean trial
found that telephone reminders following mailed notifi-
cations resulted in a higher proportion of colonoscopy
acceptance after a positive FOBT than mailed notifica-
tions alone (p = 0.038) [23]. The feasibility of telephone
contact with each FOBT-positive participant in Ontario’s
CCC is uncertain. Additionally, telephone correspond-
ence may be no more effective at improving compliance
with follow-up colonoscopy. A recent Italian RCT found
mailed invitations to be equally as effective as those con-
veyed by telephone on this outcome [24].
Though personalized mailed notifications appear to in-
crease colonoscopy uptake in population-wide screening,
it is uncertain whether these alone will be sufficient in
elevating colonoscopy uptake to match other programs.
France’s population-based screening program, including 46
out of 96 departments and the same age range as Ontario’s
CCC, reported that 88% of those receiving a positive
FOBT throughout 2008 and 2009 proceeded to follow up
colonoscopy, 90% of which occurred within 5 months [7].
England’s Bowel Cancer Screening Programme, initiated
in July of 2006, indicated that 83% of the first million
screened with FOBT in the program proceeded to colon-
oscopy [6]. While this proportion reflects only those
invited to participate in the first round of screening
(not a true population-wide sample), the elevated adher-
ence could be due to automatic referrals. In the United
Kingdom, follow-up colonoscopy appointments are cen-
trally scheduled upon a positive FOBT result, while in
Ontario, organizing follow-up is the domain of the
PCP. The implementation of automatic referrals may
be dependent on the integration of electronic medical
record systems beyond those that currently exist in
Ontario, the adoption of which trails that of the UK and
other European countries [25].
Figure 1 Observed and predicted rates of colonoscopy uptake by follow-up month from Ontario’s ColonCancerCheck program. Green
and brown vertical lines indicate implementation of strategies 1 and 2, respectively.
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These findings should be interpreted in the context of
the following strengths and limitations. To our knowledge,
this is the first population-based study assessing interven-
tions specifically designed to improve colonoscopy uptake
rates among FOBT-positive participants in an organized
screening program. Furthermore, it is the first to evaluateTable 2 Crude and multivariable-adjusted rate ratios
indicating average monthly change in colonoscopy
uptake from October 2008 through February 2011 in
Ontario’s ColonCancerCheck program
Rate ratio 95% CI p value
Pre strategy 1
Crude 1.01 (1.00–1.01) 0.002
Multivariable-adjusteda 1.01 (1.00–1.01) 0.002
Strategy 1b
Crude 1.00 (0.99–1.02) NSSd
Multivariable-adjusteda 1.00 (0.99–1.01) NSSd
Strategy 2c
Crude 1.03 (1.00–1.05) 0.04
Multivariable-adjusteda 1.03 (1.00–1.06) 0.04
aAdjusted for age, sex, SES, LHIN, total ADG score, usual provider continuity
index, repeat FOBT after index positive FOBT, and prior colonoscopy. Each
covariate was entered in the multivariable Poisson model as indicated in Table 1.
bRevision of standardized reporting of positive FOBT result to PCPs.
Implemented February 1, 2010.
cReporting of positive FOBT result directly to participants. Implemented
October 1, 2010.
dNot statistically significant.the impact of interventions on this outcome in a post-pilot
phase population-wide setting. Access to such a large, rep-
resentative FOBT-positive cohort produces results that are
arguably more generalizable to the growing number of
such programs worldwide [26].
A limitation is the 3-month maximum follow-up, mak-
ing performance comparisons with other population-
wide screening programs that have reported higher rates
of follow-up colonoscopy after longer intervals [6,7] of
uncertain utility. A second related limitation is the rela-
tively short study interval after implementation of strat-
egy 2, allowing for the modeling of only five time points.
As such, inferences made about strategy 2 are based on
fewer data and thereby may be more susceptible to bias
such as those stemming from variation in colonoscopy
utilization due to seasonal trends. We acknowledge that
this observational design does not support a causal link as
strongly as an RCT allowing randomized allocation of in-
terventions and contemporaneous comparison to controls.
However, as implementation of strategies 1 and 2 was
province-wide we did not have access to a suitable control
group. Validation of the effectiveness of direct participant
notification of screening outcomes in improving follow-up
colonoscopy compliance is pending future work.
Conclusions
Our results suggest that further refinement of mailed cor-
respondence notifying PCPs of FOBT results and remind-
ing them of the recommended follow-up protocol will be
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FOBT-positive individuals. In contrast, our findings indi-
cate that increased participant engagement may help large
population-wide programs improve adherence. Thus, it is
recommended that such programs consider interventions
that target the participant directly. Based on experience in
other jurisdictions, additional potentially useful strategies
for population-wide screening programs such as Ontario’s
CCC include system-level changes such as the implemen-
tation of centralized automatic colonoscopy referral for
persons with positive FOBT results.Additional file
Additional file 1: Sample letter to CCC participants reporting a
positive FOBT result. The letter is mailed directly to participants
informing them of a positive FOBT result and urging them to contact a
PCP to discuss appropriate diagnostic follow-up.
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